-Decay Half-Lives of Very Neutron-Rich Kr to Tc Isotopes on the Boundary of the -Process Path: An Indication of Fast -Matter FlowS Nishimura, Z Li, H Watanabe, K Yoshinaga, T Sumikama, T Tachibana, ...
Physical review letters 106 (5), 052502, 2011
214 2011 Predictive value of microalbuminuria in medical ICU patients: results of a pilot study O Abid, Q Sun, K Sugimoto, D Mercan, JL Vincent
Chest 120 (6), 1984-1988, 2001
170 2001 Neural physiology and local anesthetic action G Strichartz, E Pastijn, K Sugimoto
Cousins, MJ.; Carr, DB.; Horlocker, TT, 26-47, 2009
117 2009 Structural Evolution in the Neutron-Rich Nuclei and T Sumikama, K Yoshinaga, H Watanabe, S Nishimura, Y Miyashita, ...
Physical review letters 106 (20), 202501, 2011
105 2011 Direct observation of lattice symmetry breaking at the hidden-order transition in URu2 Si2 S Tonegawa, S Kasahara, T Fukuda, K Sugimoto, N Yasuda, Y Tsuruhara, ...
Nature communications 5 (1), 4188, 2014
85 2014 AMF-26, a novel inhibitor of the Golgi system, targeting ADP-ribosylation factor 1 (Arf1) with potential for cancer therapy Y Ohashi, H Iijima, N Yamaotsu, K Yamazaki, S Sato, M Okamura, ...
Journal of Biological Chemistry 287 (6), 3885-3897, 2012
82 2012 Tolerance against terrestrial neutron-induced single-event burnout in SiC MOSFETs H Asai, I Nashiyama, K Sugimoto, K Shiba, Y Sakaide, Y Ishimaru, ...
IEEE Transactions on Nuclear Science 61 (6), 3109-3114, 2014
80 2014 A novel compound, denosomin, ameliorates spinal cord injury via axonal growth associated with astrocyte‐secreted vimentin K Teshigawara, T Kuboyama, M Shigyo, A Nagata, K Sugimoto, ...
British journal of pharmacology 168 (4), 903-919, 2013
73 2013 Development of axial asymmetry in the neutron-rich nucleus 110Mo H Watanabe, K Yamaguchi, A Odahara, T Sumikama, S Nishimura, ...
Physics Letters B 704 (4), 270-275, 2011
68 * 2011 Partial pole placement by LQ regulators: An inverse problem approach K Sugimoto
IEEE transactions on automatic control 43 (5), 706-708, 1998
63 1998 Robust stochastic gradient descent with student-t distribution based first-order momentum WEL Ilboudo, T Kobayashi, K Sugimoto
IEEE Transactions on Neural Networks and Learning Systems 33 (3), 1324-1337, 2020
55 2020 Synthesis and antitumor evaluation of arctigenin derivatives based on antiausterity strategy N Kudou, A Taniguchi, K Sugimoto, Y Matsuya, M Kawasaki, N Toyooka, ...
European journal of medicinal chemistry 60, 76-88, 2013
49 2013 Monocyte CD40 expression in severe sepsis K Sugimoto, C Galle, JC Preiser, J Creteur, JL Vincent, O Pradier
Shock 19 (1), 24-27, 2003
44 2003 Object manifold learning with action features for active tactile object recognition D Tanaka, T Matsubara, K Ichien, K Sugimoto
2014 IEEE/RSJ International Conference on Intelligent Robots and Systems …, 2014
42 2014 Carrier-mediated uptake of 1-(2-methoxyethyl)-2-methyl-4, 9-dioxo-3-(pyrazin-2-ylmethyl)-4, 9-dihydro-1H-naphtho [2, 3-d] imidazolium bromide (YM155 monobromide), a novel small … T Minematsu, M Iwai, K Sugimoto, N Shirai, T Nakahara, T Usui, ...
Drug metabolism and disposition 37 (3), 619-628, 2009
42 2009 Pneumatic artificial muscle-driven robot control using local update reinforcement learning Y Cui, T Matsubara, K Sugimoto
Advanced Robotics 31 (8), 397-412, 2017
39 2017 Efficient approach to 1, 2-diazepines via formal diazomethylene insertion into the C–C bond of cyclobutenones K Sugimoto, R Hayashi, H Nemoto, N Toyooka, Y Matsuya
Organic letters 14 (13), 3510-3513, 2012
36 2012 Rational design and synthesis of 4-substituted 2-pyridin-2-ylamides with inhibitory effects on SH2 domain-containing inositol 5′-phosphatase 2 (SHIP2) Y Ichihara, R Fujimura, H Tsuneki, T Wada, K Okamoto, H Gouda, ...
European journal of medicinal chemistry 62, 649-660, 2013
34 2013 Kernel dynamic policy programming: Applicable reinforcement learning to robot systems with high dimensional states Y Cui, T Matsubara, K Sugimoto
Neural networks 94, 13-23, 2017
32 2017 Synthesis of dihydrofuran-fused perhydrophenanthrenes having a phenolic hydroxyl group as a novel anti-Alzheimer’s disease agent K Sugimoto, K Tamura, N Ohta, C Tohda, N Toyooka, H Nemoto, ...
Bioorganic & medicinal chemistry letters 22 (1), 449-452, 2012
31 2012